SCHEMBL8675940

SCHEMBL8675940

CCOc1cccc(-c2nc(-c3ccc(OC)cc3)ccc2-c2ccc(OC)cc2)c1N1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 5/20 0.43
PKM P14618 2/20 0.43
TSHR P16473 1/20 0.43
ADORA3 P0DMS8 1/20 0.42
HPGD P15428 5/20 0.41
HSD17B10 Q99714 5/20 0.41
MAPT P10636 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
LMNA P02545 2/20 0.41
ATM Q13315 1/20 0.41
TP53 P04637 2/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.39
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HTT P42858 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8676997 0.97 ALDH1A1 (0.43) ALDH1A1KDM4EPKMTSHRADORA3
SCHEMBL8677539 0.95 MAPT (0.43) ALDH1A1KDM4EPKMTSHRADORA3
SCHEMBL8827914 0.89 ALDH1A1 (0.38) ALDH1A1HPGDHSD17B10MAPTSMN1; SMN2
SCHEMBL8678772 0.89 ADORA3 (0.42) ALDH1A1KDM4EPKMTSHRADORA3
SCHEMBL8677612 0.88 ADORA3 (0.41) ALDH1A1KDM4EPKMTSHRADORA3
SCHEMBL8827945 0.87 ESR1 (0.40) ALDH1A1HPGDHSD17B10MAPTSMN1; SMN2
SCHEMBL8827929 0.85 GRIA1 (0.39) ALDH1A1MAPTSMN1; SMN2LMNAATM
SCHEMBL8677205 0.82 PRKDC (0.45) ALDH1A1KDM4EADORA3HPGDHSD17B10
SCHEMBL8827923 0.79 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL8827939 0.78 ALDH1A1 (0.40) ALDH1A1KDM4ETSHRHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750708-A Pyridine compounds intermediates processes compositions and methods ELI LILLY AND COMPANY (US) 1998-05-12 US disclosed
US-5672609-A POSTMENOPAUSAL SYNDROME; ANTILIPEMIC AND -CARCINOGENIC AGENTS; OSTEOPOROSIS; CARDIOTONIC AGENTS; RESTENOSIS; SIDE EFFECT REDUCTION COMPARED TO ESTROGEN ELI LILLY AND COMPANY (US) 1997-09-30 US disclosed